Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan

被引:4
作者
Khan, Yumna [1 ]
Khan, Najeeb Ullah [1 ]
Ali, Ijaz [2 ]
Khan, Samiullah [3 ]
Khan, Aakif Ullah [3 ]
Iqbal, Aqib [1 ]
Adams, Brian D. [4 ]
机构
[1] Univ Agr, Inst Biotechnol & Genet Engn, Hlth Div, Peshawar, Pakistan
[2] Gulf Univ Sci & Technol, Ctr Appl Math & Bioinformat CAMB, Hawally, Kuwait
[3] Inst Radiotherapy & Nucl Med IRNUM, Peshawar, Pakistan
[4] Brain Inst Amer, Dept RNA Sci, New Haven, CT 06511 USA
关键词
Breast cancer; Risk association; BRCA1; BRCA2; TP53; Polymorphisms; P53; CODON-72; POLYMORPHISM; OVARIAN-CANCER; PATHOLOGICAL CHARACTERISTICS; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; MUTATIONS; VARIANTS; SUSCEPTIBILITY; CARCINOMA; FREQUENCY;
D O I
10.1007/s11033-023-08463-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundSingle nucleotide polymorphism (SNPs) in BRCA1, BRCA2 and TP53 has been widely associated with breast cancer risk in different ethnicities with inconsistent results. There is no such study conducted so far in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. Therefore, this study was conducted to check BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.MethodsThis study, consisting 140 breast cancer patients and 80 gender and age matched healthy controls were subjected to confirm BRCA1, BRCA2 and TP53 polymorphism. Clinicopathological data and blood samples were taken from all the participants. DNA was extracted and SNPs were confirmed using T-ARMS-PCR protocol.ResultsOur data indicated that BRCA1, BRCA2, and TP53 selected SNPs risk allele and risk allele containing genotypes displayed significant association (p < 0.05) with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan.ConclusionAll the three selected SNPs of BRCA1, BRCA2 and TP53 showed significant association with breast cancer risk in the Pashtun population of Khyber Pakhtunkhwa, Pakistan. However, more investigation will be required on large data sets to confirm the selected SNPs and other SNPs in the selected and other related genes with the risk of breast cancer.
引用
收藏
页码:6087 / 6096
页数:10
相关论文
共 51 条
[1]  
Aabdein M., 2018, F1000RESEARCH, DOI [10.12688/f1000research.11395.4, DOI 10.12688/F1000RESEARCH.11395.4]
[2]   Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression [J].
Abubakar, Mustapha ;
Guo, Changyuan ;
Koka, Hela ;
Sung, Hyuna ;
Shao, Nan ;
Guida, Jennifer ;
Deng, Joseph ;
Li, Mengjie ;
Hu, Nan ;
Zhou, Bin ;
Lu, Ning ;
Yang, Xiaohong R. .
NPJ BREAST CANCER, 2019, 5 (1)
[3]   Compensatory Functions and Interdependency of the DNA-Binding Domain of BRCA2 with the BRCA1-PALB2-BRCA2 Complex [J].
Al Abo, Muthana ;
Dejsuphong, Donniphat ;
Hirota, Kouji ;
Yonetani, Yasukazu ;
Yamazoe, Mitsuyoshi ;
Kurumizaka, Hitoshi ;
Takeda, Shunichi .
CANCER RESEARCH, 2014, 74 (03) :797-807
[4]   Prevalence, Risk Factors and Disease Knowledge of Breast Cancer in Pakistan [J].
Asif, Hafiz Muhammad ;
Sultana, Sabira ;
Akhtar, Naveed ;
Rehman, Jalil Ur ;
Rehman, Riaz Ur .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (11) :4411-4416
[5]   Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer [J].
Atchley, Deann P. ;
Albarracin, Constance T. ;
Lopez, Adriana ;
Valero, Vicente ;
Amos, Christopher I. ;
Gonzalez-Angulo, Ana Maria ;
Hortobagyi, Gabriel N. ;
Arun, Banu K. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4282-4288
[6]  
Aziz I, 2013, PAK J ZOOL, V45, P1437
[7]   The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells [J].
Baptiste N. ;
Friedlander P. ;
Chen X. ;
Prives C. .
Oncogene, 2002, 21 (1) :9-21
[8]   iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53 [J].
Bergamaschi, Daniele ;
Samuels, Yardena ;
Sullivan, Alexandra ;
Zvelebil, Marketa ;
Breyssens, Hilde ;
Bisso, Andrea ;
Del Sal, Giannino ;
Syed, Nelofer ;
Smith, Paul ;
Gasco, Milena ;
Crook, Tim ;
Lu, Xin .
NATURE GENETICS, 2006, 38 (10) :1133-1141
[9]  
Buyru N, 2003, ONCOL REP, V10, P711
[10]   Invasive Breast Cancer [J].
Carlson, Robert W. ;
Allred, Craig ;
Anderson, Benjamin O. ;
Burstein, Harold J. ;
Carter, W. Bradford ;
Edge, Stephen B. ;
Erban, John K. ;
Farrar, William B. ;
Forero, Andres ;
Giordano, Sharon Hermes ;
Goldstein, Lori J. ;
Gradishar, William J. ;
Hayes, Daniel F. ;
Hudis, Clifford A. ;
Ljung, Britt-Marie ;
Mankoff, David A. ;
Marcom, P. Kelly ;
Mayer, Ingrid A. ;
McCormick, Beryl ;
Pierce, Lori J. ;
Reed, Elizabeth C. ;
Sachdev, Jasgit ;
Smith, Mary Lou ;
Somlo, George ;
Ward, John H. ;
Wolff, Antonio C. ;
Zellars, Richard .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (02) :136-222